Energetic Abnormalities in Heart Failure With Preserved Ejection Fraction
NCT ID: NCT00628082
Last Updated: 2008-03-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2006-03-31
2009-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Arterial Stiffening as a Predictor for Diastolic Cardiac Dysfunction and HFpEF
NCT06208007
Analysis of Heart Muscle Function Following Exercise in Patients With Heart Disease
NCT00001528
POWER Myocardial Fatigue Study: a Biomechanical Assessment of Contractility of Human Myocardium
NCT04899635
Neuromuscular Fatigability in Individuals With Heart Failure
NCT06551012
CHANges iN skEletal muscLe in Heart Failure
NCT03401151
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HfpEF
Patients with Heart Failure with preserved ejection fraction
No interventions assigned to this group
Control
Healthy Volunteers
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* LVEF ≥ 50%, with no evidence of significant valvular disease, no hypertrophic cardiomyopathy, and no evidence of pericardial constriction
* A peak VO2 \< 80% predicted, with a pattern of gas exchange on metabolic exercise testing indicating a cardiac cause for limitation
Exclusion Criteria
* Reversible myocardial ischaemia on contrast-enhanced myocardial stress
* Echocardiography, and evidence of exercise-induced mitral regurgitation
* Obesity (BMI \>35) or a locomotor cause for exercise limitation
40 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Heart of England NHS Trust
OTHER
British Heart Foundation
OTHER
University Hospital Birmingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of Birmingham
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Frenneaux, FRCP
Role: PRINCIPAL_INVESTIGATOR
University of Birmingham
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Birmingham
Birmingham, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RRK 2996
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.